Clinical Trial Update: A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing subcutaneous and intravenous rituximab in patients with follicular lymphoma to assess absorption and exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphoma, Follicular | Phase 1 | Status: COMPLETED